These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 985538)

  • 41. The control of postnatal hypoglycemia. Suggestions based on experimental observations in neonatal rats.
    Cake MH; Yeung D; Oliver IT
    Biol Neonate; 1971; 18(3):183-92. PubMed ID: 5155589
    [No Abstract]   [Full Text] [Related]  

  • 42. [Glucose metabolism during steroid and biguanide therapy using tritiated glucose].
    Bottermann P; Schweigart U; Emrmler R
    Verh Dtsch Ges Inn Med; 1975; 81():1481-4. PubMed ID: 1227002
    [No Abstract]   [Full Text] [Related]  

  • 43. [Mechanism of action of biguanides and their place in the modern therapy of diabetes mellitus].
    Fövényi J
    Orv Hetil; 1970 Jun; 111(26):1503-7. PubMed ID: 4916664
    [No Abstract]   [Full Text] [Related]  

  • 44. [On the problem of the development of lactacidosis under biguanide effect].
    Lippmann HG; Schäfer H; Zillmann R
    Dtsch Z Verdau Stoffwechselkr; 1967 Feb; 26(4):202-5. PubMed ID: 5595288
    [No Abstract]   [Full Text] [Related]  

  • 45. [Experimental studies on the mechanism of thrombocyte aggregation inhibition caused by sulfonylurea compounds. 2. Modification of blood sugar and thrombocyte aggregation by oral antidiabetics].
    Losert W; Hoder A; Scholz C
    Arzneimittelforschung; 1975 Feb; 25(2):170-9. PubMed ID: 804311
    [No Abstract]   [Full Text] [Related]  

  • 46. [Pharmacokinetics of blood glucose lowering biguanide derivatives].
    Mehnert H
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():137-42. PubMed ID: 4906018
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effect of metformin on glucose utilization and body weight].
    Irsigler K
    Dtsch Med Wochenschr; 1970 Oct; 95(43):2169-74. PubMed ID: 5477959
    [No Abstract]   [Full Text] [Related]  

  • 48. Long-term central infusion of adiponectin improves energy and glucose homeostasis by decreasing fat storage and suppressing hepatic gluconeogenesis without changing food intake.
    Park S; Kim DS; Kwon DY; Yang HJ
    J Neuroendocrinol; 2011 Aug; 23(8):687-98. PubMed ID: 21599766
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The effects of blood glucose lowering biguanides on liver metabolism].
    Söling HD
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():656-77. PubMed ID: 4906984
    [No Abstract]   [Full Text] [Related]  

  • 50. [Chemistry, toxicology, pharmacodynamics and mechanism of action of biguanides].
    Ezechieli S
    Clin Ter; 1970 Aug; 54(4):351-80. PubMed ID: 4992475
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effect of biguanides and sulfonylureas on glycemia of subjects with normal metabolism].
    Ezechieli S
    Clin Ter; 1970 Oct; 55(1):33-44. PubMed ID: 4925337
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of buformin on muscle energy metabolism.
    Strohfeldt P; Strubel U
    Horm Metab Res; 1976 May; 8(3):243. PubMed ID: 939470
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of discontinuation of biguanide therapy on metabolic control in maturity-onset diabetics.
    Siitonen O; Aro A; Huttunen JK; Juvonen H; Järvinen R; Korhonen T; Palomäki P; Ritala P
    Lancet; 1980 Feb; 1(8162):217-20. PubMed ID: 6101675
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Drug effects and clinico-chemical condition].
    Appel W
    Med Welt; 1980 Apr; 31(16):569-74. PubMed ID: 7392921
    [No Abstract]   [Full Text] [Related]  

  • 55. Mechanism of action of phenethylbiguanide in normal subjects.
    Pereira VG; Wajchenberg BL; Shnaider J
    Diabetes; 1967 May; 16(5):302-5. PubMed ID: 6022556
    [No Abstract]   [Full Text] [Related]  

  • 56. [Effect of Buformin retard in adipose patients with impaired glucose tolerance].
    Schräpler P; Schulz E; Adlung J
    Med Welt; 1975 Oct; 26(42):1919-21. PubMed ID: 1186481
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparison of McN-3495 [N-(1-methyl-2-pyrrolidinylidene)-N'-phenyl-1-pyrrolidinecarboximidamide], a new, orally effective, hypoglycemic agent, with the biguanides.
    Tutwiler GF; Bridi G
    Diabetes; 1978 Aug; 27(8):868-76. PubMed ID: 680413
    [No Abstract]   [Full Text] [Related]  

  • 58. The effect of different doses of dimethylbiguanide (DMB) on liver blood flow, blood glucose and plasma immunoreactive insulin in anaesthetized rats.
    Ohnhaus EE; Berger W; Nars PW
    Biochem Pharmacol; 1978 Mar; 27(5):789-93. PubMed ID: 656118
    [No Abstract]   [Full Text] [Related]  

  • 59. [Mechanism of action of phenethylbigunide (PEBG). V. Administration in the hyperglycemic rabbit during continous glucose perfusion].
    Fratino P; Rodari T; Maggi G
    Boll Soc Ital Biol Sper; 1967 Dec; 43(24):1889-91. PubMed ID: 5601975
    [No Abstract]   [Full Text] [Related]  

  • 60. Pancreatic glucagon, plasma insulin and blood glucose responses to arginine infusion in nondiabetic subjects following biguanide pretreatment.
    Berger W; Stahl M; Ohnhaus E; Göschke H
    Horm Metab Res; 1974 Mar; 6(2):165. PubMed ID: 4828277
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.